- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
AMAG Pharmaceuticals Inc
+ Add to WatchlistAMU:GR
19.215 EUR 0.218 1.15%As of 02:08:21 ET on 05/22/2013.
Snapshot for AMAG Pharmaceuticals Inc (AMU)
| Open: | 19.215 | Day's Range: | 19.215 - 19.215 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 18.997 | 52wk Range: | 10.115 - 19.763 | 1-Yr Rtn: | +89.35% |
Key Statistics for AMU
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.6260 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 12 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AMU
Company Profile & Key Executives for AMU
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
| William K HeidenPresident/CEO | Scott A HolmesChief Acctg Officer/Treasurer |
| Frank E ThomasExec VP/COO | Greg MadisonExec VP/Chief Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AMU News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page